Since the start of the vaccination campaign against the new coronavirus (Covid-19) in France, a share of the population has suffered from adverse effects. However, a majority of these reactions were not serious. As of June 10, 2021, French health authorities indeed recorded 26 percent of severe adverse reaction cases caused by the injection of one of the vaccines developed against the Covid-19 virus.
Breakdown of adverse effect cases seriousness caused by vaccines against the coronavirus (Covid-19) among the French population as of June 10, 2021, by type of vaccine
Characteristic
Non-serious adverse effects
Serious adverse effects
All types
74%
26%
BioNTech-Pfizer
72%
28%
AstraZeneca
75%
25%
Moderna
80%
20%
Janssen
58%
42%
Created with Highcharts 7.2.2Share of adverse effect cases74%74%72%72%75%75%80%80%58%58%26%26%28%28%25%25%20%20%42%42%Non-serious adverse effectsSerious adverse effectsAll typesBioNTech-PfizerAstraZenecaModernaJanssen
0%25%50%75%100%125%
Add this content to your personal favorites. These can be accessed from the favorites menu in the main navigation.
Adjust the presentation of the statistic and data points.
Share the statistic on social media channels or embed the statistic in your
website using "Embed Code", where available.
Cite this statistic and select one of the following formats: APA, Chicago, Harvard, MLA & Bluebook.
Print the statistic including description and metadata.
Chart type
Breakdown of adverse effect cases seriousness caused by vaccines against the coronavirus (Covid-19) among the French population as of June 10, 2021, by type of vaccine
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
Learn more about how Statista can support your business.
ANSM. (June 23, 2021). Breakdown of adverse effect cases seriousness caused by vaccines against the coronavirus (Covid-19) among the French population as of June 10, 2021, by type of vaccine [Graph]. In Statista. Retrieved May 10, 2025, from https://www.statista.com/statistics/1225100/adverse-effect-cases-seriousness-covid-19-vaccines-france/
ANSM. "Breakdown of adverse effect cases seriousness caused by vaccines against the coronavirus (Covid-19) among the French population as of June 10, 2021, by type of vaccine." Chart. June 23, 2021. Statista. Accessed May 10, 2025. https://www.statista.com/statistics/1225100/adverse-effect-cases-seriousness-covid-19-vaccines-france/
ANSM. (2021). Breakdown of adverse effect cases seriousness caused by vaccines against the coronavirus (Covid-19) among the French population as of June 10, 2021, by type of vaccine. Statista. Statista Inc.. Accessed: May 10, 2025. https://www.statista.com/statistics/1225100/adverse-effect-cases-seriousness-covid-19-vaccines-france/
ANSM. "Breakdown of Adverse Effect Cases Seriousness Caused by Vaccines against The Coronavirus (Covid-19) among The French Population as of June 10, 2021, by Type of Vaccine." Statista, Statista Inc., 23 Jun 2021, https://www.statista.com/statistics/1225100/adverse-effect-cases-seriousness-covid-19-vaccines-france/
ANSM, Breakdown of adverse effect cases seriousness caused by vaccines against the coronavirus (Covid-19) among the French population as of June 10, 2021, by type of vaccine Statista, https://www.statista.com/statistics/1225100/adverse-effect-cases-seriousness-covid-19-vaccines-france/ (last visited May 10, 2025)
Breakdown of adverse effect cases seriousness caused by vaccines against the coronavirus (Covid-19) among the French population as of June 10, 2021, by type of vaccine [Graph], ANSM, June 23, 2021. [Online]. Available: https://www.statista.com/statistics/1225100/adverse-effect-cases-seriousness-covid-19-vaccines-france/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.